@inproceedings{inproceedings, title = {{Progressive and sustained Disease Control in Patients with atopic Dermatitis (AD) aged 12 to 17 Years treated with Tralokinumab for 52 Weeks}}, url = {{}}, year = {{2024}}, month = {{1}}, author = {{Wollenberg A and Cork M and Chih-ho-Hong H and Kurbasic A and Vacko E and Paller AS}}, volume = {{47}}, journal = {{ALLERGOLOGIE}}, issue = {{9}}, note = {{Accessed on 2025/05/28}}}